Top

Reactions Weekly

Published in:

01-12-2023 | Natalizumab | Case report

Mefloquine/mirtazapine/natalizumab

Progressive multifocal leukoencephalopathy and lack of efficacy: case report

Published in: Reactions Weekly | Issue 1/2023

Excerpt

Author Information

An event is serious (based on the ICH definition) when the patient outcome is:

* death
* life-threatening
* hospitalisation
* disability
* congenital anomaly
* other medically important event

…

Sugimoto T, et al. A case of natalizumab-associated progressive multifocal leukoencephalopathy followed by immune reconstitution inflammatory syndrome with difficulty in the timing of immunotherapy. Clinical and Experimental Neuroimmunology 14: 110-115, No. 2, 18 Oct 2022. Available from: URL: http://doi.org/10.1111/cen3.12734

Title: Mefloquine/mirtazapine/natalizumab
Progressive multifocal leukoencephalopathy and lack of efficacy: case report
Publication date: 01-12-2023
Publisher: Springer International Publishing
Keywords: Natalizumab
Mefloquine
Mirtazapine
Mirtazapine
Human interferon beta
Multiple Sclerosis
Aphasia
Published in: Reactions Weekly / Issue 1/2023
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-023-51555-0

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Mefloquine/mirtazapine/natalizumab

Progressive multifocal leukoencephalopathy and lack of efficacy: case report

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2023

Multiple drugs

Everolimus/mycophenolate-mofetil/prednisone

Blinatumomab/Inotuzumab-ozogamicin

Camrelizumab

Pembrolizumab

Insulin